Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 178.38 billion as of April 29, 2026. Its market cap has decreased by -3.63% in one year.

Market Cap

178.38B

Enterprise Value

140.34B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

7,640.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 178.38B, an increase of 11.32%. That is a compound annual growth rate of 1.93%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	178.38B	-23.22%
Dec 30, 2025	232.34B	-3.12%
Dec 30, 2024	239.82B	-53.54%
Dec 28, 2023	516.20B	-0.71%
Dec 29, 2022	519.87B	-21.31%
Dec 30, 2021	660.68B	-73.75%
Dec 30, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ENCell	181.08B
Macrogen	183.22B
MedPacto	188.17B
Amicogen	133.16B
Genexine	259.69B
JETEMA,	260.84B
EASY BIO,Inc.	261.68B
iNtRON Biotechnology	119.66B

Market Cap Rankings